Traditional Chinese Medicine Yimucao Injection Combined with Western Medicine for Preventing Postpartum Hemorrhage after Cesarean Section: A Systematic Review and Meta-Analysis

Table 1

Characteristics of included articles.

Study	Sample	Age	Intervention		Follow-up	Evaluation
	(T/C)	(T/C)	T	C
Peng and Li, 2017 [22]	250/250	28.32/27.45	YM+OT	OT	NR	①②③④
Ban, 2017 [26]	64/64	28.45/27.56	YM+OT	OT	4d	②③④
Sun, 2017 [47]	40/40	34.98/35.41	YM+OT	OT	3d	③④
Li et al., 2015 [27]	75/75	25.2	YM+OT	OT	NR	②③④
Du, 2015 [10]	80/80	29.6/29.7	YM+OT	OT	3d	①②③④
Shi, 2015 [28]	34/34	NR	YM+OT	OT	3d	②④
Ma, 2012 [11]	256/256	24.46/24.18	YM+OT	OT	NR	②③④
Chen, 2011 [29]	100/100	29	YM+OT	OT	3d	②③④
Fu, 2011 [30]	63/63	NR	YM+OT	OT	NR	②③④
Lin et al., 2009 [12]	144/149	NR	YM+OT	OT	NR	②③④
Shen, 2018 [13]	57/57	27.95/27.86	YM+CT	CT	NR	②③④
Li and Tan, 2017 [14]	90/87	28.7/29.2	YM+CT	OT	3d	①②③④
Ye, 2016 [48]	98/98	28.89/29.56	YM+CT	CT	2d	③④
Yang, 2015 [49]	70/70	28.8/29.0	YM+CT	CT	2d	③④
Chou et al., 2015 [50]	52/52	26.6/27.3	YM+CT	OT	NR	③④
Ding et al., 2014 [15]	60/60	NR	YM+CT	OT	NR	③④
You, 2016 [31]	50/50	28	YM+OT	OT	NR	②③④
Zhang, 2016 [51]	37/37	26.3/27.9	YM+OT	OT	NR	③④
Li, 2016 [16]	45/45	24.9/24.7	YM+OT	OT	NR	②③④
Liu, 2015 [23]	50/50	28.11/27.81	YM+OT	OT	NR	①②③④
Qin, 2015 [52]	59/59	28.3/28.5	YM+OT	OT	NR	③④
Deng, 2014 [53]	68/68	28.4/29.3	YM+OT	OT	3d	③④
Xie, 2013 [32]	100/100	NR	YM+OT	OT	3d	②③④
Lu, 2013 [45]	129/129	27.5/27.9	YM+OT	OT	NR	②③④
Liu, 2009 [33]	200/200	NR	YM+OT	OT	NR	②③④
Chen, 2009 [44]	100/100	NR	YM+OT	OT	NR	②③④
Ma, 2018 [54]	30/30	29.26/28.95	YM+CT	CT	2d	③④
Wang and Feng, 2013 [34]	40/40	25.2/27.4	YM+MS+OT	MS+OT	NR	②③④
Liu, 2013 [35]	65/65	25/25.2	YM+MS	OT	NR	②③④
Li, 2010 [36]	100/100	NR	YM+OT	OT	NR	②③④
Wu et al., 2012 [37]	30/30	NR	YM+OT	OT	NR	②③④
Yang and Pei, 2014 [24]	50/50	28.09/28.16	YM+OT	OT	NR	①②③④
Liang, 2017 [17]	50/50	29.6/29.3	YM+OT	OT	NR	①②③④
Luo, 2017 [38]	60/60	29.7/29.1	YM+OT	OT	NR	②③④
Guo, 2010 [39]	50/50	27.0/30.5	YM+OT	OT	NR	②③④
Guo, 2016 [25]	60/60	30.2/30.5	YM+OT	OT	NR	①②③④
Huang, 2015 [46]	36/36	27.2	YM+OT	OT	NR	②③④
Gong, 2013 [40]	110/110	NR	YM+OT	OT	NR	②④
Wu, 2015 [41]	103/101	24.56	YM+OT	OT	NR	②③④
Zhang, 2017 [42]	100/100	22/23	YM+OT	OT	NR	②③④
Zhao, 2017 [18]	46/46	28.23/28.62	YM+OT	OT	NR	②③④
Sun, 2017 a[19]	53/53	28.09/28.21	YM+CT	CT	2d	③④
Mou, 2017 [43]	52/52	31.62/31.59	YM+CT	CT	NR	②③④
Ma, 2017 [20]	40/40	28.13/28.46	YM+CT	CT	NR	③④
Li, 2014 [55]	40/40	NR	YM+CT	CT	NR	③④
Gong, 2017 [21]	51/51	29.03/28.47	YM+CT	CT	2d	③④
Fu, 2012 [56]	46/46	26.6	YM+MS	OT	NR	③④
Chen, 2017 [57]	84/84	24.3/24.7	YM+MS	MS	3d	③④

Note. T: treatment group; C: control group; d: days; NR: not report; YM: Yimucao injection; OT: oxytocin; CT: carboprost tromethamine; MS: misoprostol; ①: the total effective rate; ②: intraoperative blood loss; ③: blood loss within 2 hours; ④: blood loss within 24 hours.